Burstable Cannabis Team
Cannabis In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
614 articles
Articles
NRx Pharmaceuticals Reports Narrowed Q1 Losses and Advances in Ketamine and Bipolar Depression Treatments
NRx Pharmaceuticals (NASDAQ: NRXP) has reported a net loss of $5.5 million for Q1 2025, marking an improvement from the $6.5 million loss recorded in the same period the previous year. The company's operating losses also saw a reduction, narrowing down to $3.8 million. This financial update comes as NRx Pharmaceuticals make...
May 16, 2025Read more
Unpaid Invoices Threaten Stability in the Cannabis Industry
The cannabis industry is currently facing a significant financial crisis that could have far-reaching implications for businesses across the supply chain. At the heart of this issue is the alarming increase in unpaid invoices, a problem that has been largely overlooked despite its potential to destabilize the sector. While ...
May 15, 2025Read more
Leafwire Media and CannaSpyglass Forge Strategic Partnership to Elevate Cannabis Industry Intelligence
Leafwire Media, the leading B2B networking platform for the cannabis, hemp, and psychedelics industries, and CannaSpyglass, a premier cannabis data and market intelligence provider, today announced a strategic partnership. This collaboration provides cannabis businesses and professionals with access to critical industry inf...
May 15, 2025Read more
Cybin Partners with Thermo Fisher Scientific to Advance CYB003 for Major Depressive Disorder
Cybin Inc., a clinical-stage biopharmaceutical company, has announced a strategic partnership with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin treatment for major depressive disorder (MDD). This agreement enhances Cybin...
May 15, 2025Read more
Silo Pharma Partners with Veloxity Labs for PTSD Treatment Study
Silo Pharma (NASDAQ: SILO) has announced a partnership with Veloxity Labs to conduct GLP-compliant bioanalysis for its SPC-15 intranasal treatment study, aimed at preventing PTSD. This collaboration marks a significant step towards submitting an investigational new drug application to the FDA by 2025. The success of this st...
May 15, 2025Read more
New York Governor Excludes Controversial Cannabis Smell Provision from State Budget
Governor Kathy Hochul signed New York's latest budget into law, notably excluding a contentious proposal that would have permitted police to consider the smell of cannabis as grounds for suspecting a driver of impairment and requiring a drug test. This omission is seen as a relief for the cannabis industry and advocates who...
May 14, 2025Read more
NRx Pharmaceuticals to Report Q1 2025 Financial Results Following Strategic Acquisition in Psychedelic Research
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is set to disclose its first quarter 2025 financial outcomes on Thursday, May 15, after the market closes. This announcement will be complemented by a conference call and webcast at 4:30 p.m. ET, available through the company's investor relations site or via telephone. This financial ...
May 14, 2025Read more
Whoopi Goldberg to Launch Whoop-Tea at Cannabis Means Business 2025
Whoopi Goldberg, an Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur, is set to participate in a fireside chat at Cannabis Means Business (CMB) 2025, where she will also launch her new hemp-derived beverage, Whoop-Tea. The event is scheduled for June 4–5 at the Javits Center in New York City. Goldber...
May 14, 2025Read more
Cybin CEO to Share Insights on Psychedelic Therapeutics at Global Healthcare Showcase
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company, announced that its CEO Doug Drysdale will engage in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. This event, set to be webcast live at 1:40 p.m. ET, offers a platform for Drysdale...
May 14, 2025Read more
Trump Withdraws Nomination of Ed Martin, Impacting Cannabis Industry
The recent decision by President Donald Trump to withdraw the nomination of Ed Martin for the position of U.S. attorney for Washington, D.C., has been met with relief by the broader marijuana industry. Martin's stance on cannabis was viewed as potentially unfavorable to the industry, making his withdrawal a significant deve...
May 13, 2025Read more
RAW® Rolling Papers Achieves 300 Million+ Organic Views on Meta Platforms in April 2025
20-Year-Old Brand Organically Shatters Social Media Expectations; Solidifies Position as One of The Most Influential Brands in the Industry
May 13, 2025Read more
Pennsylvania Moves Closer to State-Oversee Cannabis Sales
The Pennsylvania State House has taken a significant step toward legalizing state-overseen cannabis sales, with House Democrats narrowly approving the measure in the Health Committee by a 14-12 vote. This development is part of a broader drug policy reform movement sweeping across states that have maintained prohibitive pol...
May 12, 2025Read more
Cannabis Means Business Expo Unveils Speaker Lineup and Highlights New York's Market Potential
The Cannabis Means Business (CMB) Expo, a leading business-to-business conference in the cannabis industry, has recently disclosed additional details about its upcoming event, including a distinguished lineup of speakers and a comprehensive schedule of panels, presentations, and networking opportunities. Among the notable s...
May 12, 2025Read more
New Research Highlights Risks of Cannabis Use During Pregnancy
Recent findings from a large-scale review of studies have brought to light the potential dangers of using cannabis during pregnancy. The research establishes a connection between prenatal cannabis use and adverse outcomes such as low birth weight, premature birth, and in severe cases, infant death. This revelation comes at ...
May 9, 2025Read more
Canadian Study Highlights Risks and Opportunities in Cannabis Use Among Young Adults
A recent Canadian study has provided valuable insights into the behaviors and personal characteristics associated with higher risks of marijuana-related problems among young adults. This research comes at a time when the cannabis industry is experiencing significant growth, creating numerous opportunities for businesses and...
May 8, 2025Read more
Cybin Secures U.S. Patent for CYB003 Program, Advancing Psychedelic-Based Treatment for Major Depressive Disorder
Cybin Inc., a clinical-stage neuropsychiatry company, has announced the issuance of U.S. patent 12,291,499 for its CYB003 program, targeting major depressive disorder (MDD). This patent covers pharmaceutical compositions and oral dosage forms related to Cybin’s proprietary deuterated psilocin analog, ensuring exclusivity th...
May 8, 2025Read more
Love Yer Brain and MoreBetter Launch Pioneering Study on THC-Infused Beverages
Love Yer Brain (Wayne Coyne) via Iconic Tonics joins MoreBetter for a pioneering study. 2,000 consumers will provide real-world data on hemp-THC beverage impact on mood, quality of life, and alcohol use, offering timely insights as demand for alternatives rises for holidays & summer.
May 7, 2025Read more
Navigating Advertising Challenges in the Cannabis Industry
The cannabis industry encounters significant challenges in advertising, unlike any other sector, due to a complex web of regulations that restrict how businesses can promote their products. These limitations are often viewed as constraints on free speech, as they prevent companies from sharing accurate information about the...
May 7, 2025Read more
Federal Scrutiny on D.C.'s Cannabis Laws Sparks Industry Concern
Washington, D.C.'s cannabis industry is under scrutiny as recent federal moves question the city's handling of marijuana laws, causing unease among major players such as Curaleaf Holdings Inc. (Cboe CA: CURA) (OTCQX: CURLF). This development comes at a time when the city is already facing significant challenges, including j...
May 6, 2025Read more
New Nonprofit 7-HOPE Alliance Launches to Advocate for 7-OHM Access and Research
The launch of the 7-HOPE Alliance represents a significant step forward in the advocacy for 7-hydroxymitragynine (7-OHM), a compound derived from kratom that has shown promise as a safer alternative to traditional painkillers and illicit substances. Amid growing debates and legislative challenges across the U.S., the nonpro...
May 6, 2025Read more
Cannadelic Miami 2025 Conference to Explore Emerging Therapies and Plant-Based Medicine
The NECANN Cannadelic Miami 2025 conference scheduled for May 23-24, 2025 at the Miami Airport Convention Center represents a significant gathering for professionals and enthusiasts in the cannabis and psychedelic industries. This two-day event will bring together researchers, scholars, wellness seekers, and industry expert...
May 6, 2025Read more